Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2009 | 12-2008 | |
| Sales | 409 | 81 | 664 | 12,170 | 0 |
| Gross Profit | 409 | 81 | 664 | 12,170 | 8,710 |
| Operating Expenses | 14,519 | 12,465 | 4,657 | 10,470 | 15,180 |
| Operating Income | -14,110 | -12,384 | -3,993 | 1,700 | -15,180 |
| Interest Expense | 0 | 233 | 339 | 0 | 0 |
| Other Income | 37,219 | -51,966 | 103 | 6,240 | 0 |
| Pre-tax Income | 23,109 | -64,583 | -4,229 | 7,940 | -15,180 |
| Net Income Continuous | 23,109 | -64,583 | -4,229 | 3,713 | -11,763 |
| Net Income Discontinuous | N/A | N/A | 3,150 | 0 | N/A |
| Net Income | $23,109 | $-64,583 | $-1,079 | $7,940 | $-11,763 |
| EPS Basic Total Ops | 589.64 | -4,481.79 | -140.06 | 2,731.09 | -7,282.91 |
| EPS Basic Continuous Ops | 863.77 | -4,468.90 | -630.25 | 1,280.35 | -4,201.07 |
| EPS Basic Discontinuous Ops | N/A | N/A | 490.20 | N/A | N/A |
| EPS Diluted Total Ops | -326.33 | -4,481.79 | -140.06 | 2,731.09 | -7,282.91 |
| EPS Diluted Continuous Ops | 549.78 | -4,468.90 | -630.25 | 1,280.35 | -4,201.07 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 490.20 | N/A | N/A |
| EBITDA(a) | $-13,952 | $-9,635 | $-3,933 | $1,700 | $-14,670 |